kaveri seeds

Upload: nandeesh-kodimallaiah

Post on 03-Jun-2018

225 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/12/2019 kaveri seeds

    1/5

    l Equity Researchl

    Important disclosures can be found in the Disclosures AppendixAll rights reserved. Standard Chartered Bank 2014 http://research.standardchartered.com

    India lEmerging Companies 26 March 2014

    Kaveri Seed

    Ripening

    We downgrade Kaveri Seed (KSL) to In-Line from

    Outperform, as the shares have reached our price target

    following the strong rise over the past month.

    We continue to like the longer term structural story but

    would advise investors to wait for a better entry point.

    We believe the current share price adequately captures

    recent news flow around genetically modified seeds.

    In our view, the biggest near-term risk remains the potentialdevelopment of a strong El Nino and resulting poor

    monsoons in India.

    IN-LINE (from OUTPERFORM)

    Downgrade to In-Line. We downgrade KSL to In-Line as the

    shares are trading at our price target. We maintain our March 2015

    price target of INR 600 and our estimates.

    Structural story intact. We believe the structural story for KSL

    remains strong, as highlighted in our SCout reportIndia agriculture

    inputs Seeds of prosperity, published 26 February 2014.

    However, we believe current valuations (c.16x 12-month forward

    PER) adequately capture the positives and think the share price islikely to consolidate at these levels.

    Genetically modified seeds major opportunity. We believe

    recent government actions signal the increasing acceptability of

    genetically modified (GM) seeds in policymaking circles. However,

    we think commercialisation of GM seeds for crops besides cotton

    is not likely in the immediate future given the outgoing government

    has merely allowed field trials of GM seeds for other crops. That

    said, we believe any eventual adoption of GM seeds for other

    crops would be a material positive for KSL, providing it with a long-

    term growth path over and above the current trajectory.

    Monsoons biggest near-term risk.The biggest near-term risk

    for KSL, as with all agro input companies, remains the increasing

    possibility of a strong El Nino and the consequent impact on Indian

    monsoons.

    Source: Company, Standard Chartered Research estimates

    Share price performance

    Source: Company, FactSet

    PRICE as of 25 Mar 2014

    INR 592.75

    PRICE TARGET

    INR 600.00

    Bloomberg code Reuters code

    KSCL IN KVRI.BO

    Market cap 12-month range

    INR 40,610mn (USD 671mn) INR 224.81 - 628.70

    EPS adj. est. change 2014E - 2015E -

    Year-end: March 2013 2014E 2015E 2016E

    Sales (INR mn) 7,120 9,956 12,390 14,991

    EBITDA (INR mn) 1,393 2,153 2,858 3,511

    EBIT (INR mn) 1,271 1,992 2,668 3,288

    Pre-tax profit (INR mn) 1,319 2,088 2,822 3,534

    Net profit adj. (INR mn) 1,267 2,026 2,596 3,181

    FCF (INR mn) 592 1,118 2,053 2,647

    EPS adj. (INR) 18.43 29.57 37.90 46.43

    DPS (INR) 3.20 5.91 7.58 9.29

    Book value/share (INR) 50.33 72.98 102.01 137.58

    EPS growth adj. (%) 99.2 60.4 28.2 22.5

    DPS growth (%) 300.0 84.8 28.2 22.5

    EBITDA margin (%) 19.6 21.6 23.1 23.4

    EBIT margin (%) 17.8 20.0 21.5 21.9

    Net margin adj. (%) 17.8 20.3 21.0 21.2

    Div. payout (%) 17.1 20.0 20.0 20.0

    Net gearing (%) - - - -

    ROE (%) 43.7 48.0 43.3 38.8

    ROCE (%) 42.6 46.7 44.2 39.8

    EV/sales (x) 1.8 3.9 3.0 2.3

    EV/EBITDA (x) 9.1 17.9 13.0 10.0

    PBR (x) 4.8 8.1 5.8 4.3

    PER adj. (x) 11.0 20.0 15.6 12.8

    Dividend yield (%) 1.6 1.0 1.3 1.6

    200

    425

    650

    Mar-13 Jun-13 Sep-13 Dec-13 Mar-14

    Kaveri Seed BSE SENSEX 30 INDEX (rebased)

    Share price (%) -1 mth -3 mth -12 mth

    Ordinary shares 16 70 162

    Relative to index 9 62 122

    Relative to sector - - -

    Major shareholder G V Bhaskar Rao (25.1%)

    Free float 36%

    Average turnover (USD) 971,404

    Sumit [email protected]

    +91 22 4205 5916

    C L I

    I 5 . 5

    I 0 0 . 00

    https://research.standardchartered.com/configuration/ROW%20Documents/India_agriculture_inputs__Seeds_of_prosperity_26_02_14_15_05.pdfhttps://research.standardchartered.com/configuration/ROW%20Documents/India_agriculture_inputs__Seeds_of_prosperity_26_02_14_15_05.pdfhttps://research.standardchartered.com/configuration/ROW%20Documents/India_agriculture_inputs__Seeds_of_prosperity_26_02_14_15_05.pdfhttps://research.standardchartered.com/configuration/ROW%20Documents/India_agriculture_inputs__Seeds_of_prosperity_26_02_14_15_05.pdfhttps://research.standardchartered.com/configuration/ROW%20Documents/India_agriculture_inputs__Seeds_of_prosperity_26_02_14_15_05.pdfhttps://research.standardchartered.com/configuration/ROW%20Documents/India_agriculture_inputs__Seeds_of_prosperity_26_02_14_15_05.pdfhttps://research.standardchartered.com/configuration/ROW%20Documents/India_agriculture_inputs__Seeds_of_prosperity_26_02_14_15_05.pdfhttps://research.standardchartered.com/configuration/ROW%20Documents/India_agriculture_inputs__Seeds_of_prosperity_26_02_14_15_05.pdf
  • 8/12/2019 kaveri seeds

    2/5

    Equity Research lKaveri Seed

    26 March 2014 2

    Figure 1: KSL forward PER

    Source: Standard Chartered Research

    0

    2

    4

    6

    8

    10

    12

    14

    16

    18

    Jan-0

    9

    Mar-09

    May-0

    9

    Jul-09

    Sep-0

    9

    Nov-0

    9

    Jan-1

    0

    Mar-10

    May-1

    0

    Jul-10

    Sep-1

    0

    Nov-1

    0

    Jan-1

    1

    Mar-11

    May-1

    1

    Jul-11

    Sep-1

    1

    Nov-1

    1

    Jan-1

    2

    Mar-12

    May-1

    2

    Jul-12

    Sep-1

    2

    Nov-1

    2

    Jan-1

    3

    Mar-13

    May-1

    3

    Jul-13

    Sep-1

    3

    Nov-1

    3

    Jan-1

    4

    Mar-14

    PERmultiple

    Kaveri Seeds forward PER Average +1 SD -1 SD

    Target PER 13x

  • 8/12/2019 kaveri seeds

    3/5

    Equity Research lKaveri Seed

    26 March 2014 3

    Source: Company, Standard Chartered Research estimates

    Income statement (INR mn) Cash flow statement (INR mn)

    Year-end: Mar 2012 2013 2014E 2015E 2016E Year-end: Mar 2012 2013 2014E 2015E 2016E

    Sales 3,724 7,120 9,956 12,390 14,991 EBIT 670 1,271 1,992 2,668 3,288

    Gross profit 2,315 3,966 6,272 7,806 9,444 Depreciation & amortisation 100 122 161 190 223

    SG&A (257) (325) (559) (685) (822) Net interest (7) 34 96 154 246

    Other income - - - - - Tax paid (29) (38) (63) (226) (353)

    Other expenses (1,389) (2,370) (3,721) (4,452) (5,334) Changes in working capital 401 (317) (769) (333) (356)

    EBIT 670 1,271 1,992 2,668 3,288 Others (53) 13 0 0 0

    Net interest (7) 34 96 154 246 Cash flow from operations 1,082 1,086 1,418 2,453 3,047

    Associates - - - - -

    Other non-operational - - - - - Capex (51) (494) (300) (400) (400)

    Exceptional items (53) 13 0 0 0 Acquisitions & Investments - - - - -

    Pre-tax profit 610 1,319 2,088 2,822 3,534 Disposals - - - - -

    Taxation (29) (38) (63) (226) (353) Others (107) 82 0 0 0

    Minority interests - - - - - Cash flow from investing (158) (412) (300) (400) (400)

    Net profit 581 1,281 2,026 2,596 3,181 Dividends (55) (219) (474) (608) (744)

    Issue of shares (7) (27) 0 0 0

    Net profit adj. 634 1,267 2,026 2,596 3,181 Change in debt (61) (187) 0 0 0

    EBITDA 770 1,393 2,153 2,858 3,511 Other financing cash flow 0 0 0 0 0

    Cash flow from financing (123) (433) (474) (608) (744)EPS (INR) 8.48 18.69 29.57 37.90 46.43

    EPS adj. (INR) 9.25 18.43 29.57 37.90 46.43 Change in cash 801 241 644 1,445 1,903

    DPS (INR) 0.80 3.20 5.91 7.58 9.29 Exchange rate effect - - - - -

    Avg fully diluted shares (mn) 69 69 69 69 69 Free cash flow 1,031 592 1,118 2,053 2,647

    Balance sheet (INR mn) Financial ratios and other Year-end: Mar 2012 2013 2014E 2015E 2016E Year-end: Mar 2012 2013 2014E 2015E 2016E

    Cash 96 143 786 2,232 4,134 Operating ratios

    Short-term investments 1,106 1,290 1,290 1,290 1,290 Gross margin (%) 62.2 55.7 63.0 63.0 63.0

    Accounts receivable 285 686 1,637 2,037 2,464 EBITDA margin (%) 20.7 19.6 21.6 23.1 23.4

    Inventory 3,033 4,912 5,455 6,789 8,214 EBIT margin (%) 18.0 17.8 20.0 21.5 21.9

    Other current assets 140 113 113 113 113 Net margin adj. (%) 17.0 17.8 20.3 21.0 21.2

    Total current assets 4,661 7,143 9,281 12,460 16,216 Effective tax rate (%) 4.7 2.9 3.0 8.0 10.0

    Sales growth (%) 59.4 91.2 39.8 24.4 21.0

    PP&E 1,066 1,445 1,584 1,794 1,971 Net income growth (%) 36.8 120.4 58.2 28.2 22.5Intangible assets 7 11 11 11 11 EPS growth (%) 36.8 120.4 58.2 28.2 22.5

    Associates and JVs - - - - - EPS growth adj. (%) 49.2 99.2 60.4 28.2 22.5

    Other long-term assets 151 77 77 77 77 DPS growth (%) 60.0 300.0 84.8 28.2 22.5

    Total long-term assets 1,225 1,533 1,672 1,882 2,059

    Efficiency ratios

    Total assets 5,886 8,676 10,953 14,342 18,275 ROE (%) 27.0 43.7 48.0 43.3 38.8

    ROCE (%) 30.4 42.6 46.7 44.2 39.8

    Short-term debt 192 23 23 23 23 Asset turnover (x) 0.8 1.0 1.0 1.0 0.9

    Accounts payable 1,100 2,486 3,273 4,073 4,928 Op. cash/EBIT (x) 1.6 0.9 0.7 0.9 0.9

    Other current liabilities 2,125 2,674 2,612 3,212 3,853 Depreciation/capex (x) 2.0 0.2 0.5 0.5 0.6

    Total current liabilities 3,417 5,182 5,908 7,308 8,804 Inventory days 606.5 459.7 513.6 487.5 493.6

    Accounts receivable days 31.7 24.9 42.6 54.1 54.8

    Long-term debt 26 8 8 8 8 Accounts payable days 192.0 207.5 285.3 292.5 296.2

    Convertible bonds - - - - -

    Deferred tax 0 0 0 0 0 Leverage ratios

    Other long-term liabilities 29 37 37 37 37 Net gearing (%) - - - - -Total long-term liabilities 55 45 45 45 45 Debt/capital (%) - - - - -

    Interest cover (x) 20.5 84.3 nm nm nm

    Total liabilities 3,472 5,227 5,953 7,353 8,849 Debt/EBITDA (x) - - - - -

    Current ratio (x) 1.4 1.4 1.6 1.7 1.8

    Shareholders funds 2,414 3,448 5,000 6,989 9,425

    Minority interests - - - - - Valuation

    EV/sales (x) 1.5 1.8 3.9 3.0 2.3

    Total equity - - - - - EV/EBITDA (x) 7.3 9.1 17.9 13.0 10.0

    EV/EBIT (x) 8.4 10.0 19.4 13.9 10.7

    Total liabilities and equity 5,886 8,676 10,953 14,342 18,275 PER (x) 10.6 10.8 20.0 15.6 12.8

    PER adj. (x) 9.7 11.0 20.0 15.6 12.8

    Net debt (cash) (984) (1,402) (2,046) (3,491) (5,394) PBR (x) 3.3 4.8 8.1 5.8 4.3

    Year-end shares (mn) 69 69 69 69 69 Dividend yield (%) 0.9 1.6 1.0 1.3 1.6

  • 8/12/2019 kaveri seeds

    4/5

    Equity Research lKaveri Seed

    26 March 2014 4

    Disclosures appendixThe information and opinions in this report were prepared by Standard Chartered Bank (Hong Kong) Limited, Standard Chartered Bank Singapore Branch, StandardChartered Securities (India) Limited, Standard Chartered Securities Korea Limited and/or one or more of its affiliates (together with its group of companies, SCB)and the research analyst(s) named in this report. THIS RESEARCH HAS NOT BEEN PRODUCED IN THE UNITED STATES.

    Analyst Certification Disclosure:The research analyst or analysts responsible for the content of this research report certify that: (1) the views expressed andattributed to the research analyst or analysts in the research report accurately reflect their personal opinion(s) about the subject securities and issuers and/or othersubject matter as appropriate; and (2) no part of his or her compensation was, is or will be directly or indirectly related to the specific recommendations or viewscontained in this research report. On a general basis, the efficacy of recommendations is a factor in the performance appraisals of analysts.

    Where disclosure date appears below, this means the day prior to the report date. All share prices quoted are the closing p rice for the business day prior to thedate of the report, unless otherwise stated.

    63.02

    170.42

    277.81

    385.21

    492.60

    600.00

    Apr-11 Jul-11 Oct-11 Jan-12 Apr-12 Jul-12 Oct-12 Jan-13 Apr-13 Jul-13 Oct-13 Jan-14 Apr-14

    INR Recommendation and price target history for Kaveri Seed

    1

    Date Recommendation Price target Date Recommendation Price target Date Recommendation Price target

    1 26 Feb 14 OUTPERFORM 600.00 Source: FactSet prices, SCB recommendations and price targets

    Recommendation Distribution and Investment Banking Relationships

    % of covered companiescurrently assigned this rating

    % of companies assigned this rating with which SCB has providedinvestment banking services over the past 12 months

    OUTPERFORM 53.2% 14.5%IN-LINE 35.2% 12.8%

    UNDERPERFORM 11.6% 8.3%

    As of 31 December 2013

    Research Recommendation

    Terminology Definitions

    OUTPERFORM (OP) The total return on the security is expected to outperform the relevant market index by 5% or more over the next 12 months

    IN-LINE (IL)The total return on the security is not expected to outperform or underperform the relevant market index by 5% or more over the next12 months

    UNDERPERFORM (UP) The total return on the security is expected to underperform the relevant market index by 5% or more over the next 12 months

    SCB uses an investment horizon of 12 months for its price targets.

    Additional information, including disclosures, with respect to any securities referred to herein will be available upon request. Requests should be sent [email protected].

    Global Disclaimer: Standard Chartered Bank and/or its affiliates ("SCB) makes no representation or warranty of any kind, express, implied or statutory regardingthis document or any information contained or referred to in the document. The information in this document is provided for information purposes only. It does notconstitute any offer, recommendation or solicitation to any person to enter into any transaction or adopt any hedging, trading or investment strategy, nor does itconstitute any prediction of likely future movements in rates or prices or represent that any such future movements will not exceed those shown in any illustration.The stated price of the securities mentioned herein, if any, is as of the date indicated and is not any representation that any transaction can be effected at this price.While all reasonable care has been taken in preparing this document, no responsibility or liability is accepted for errors of fact or for any opinion expressed herein.The contents of this document may not be suitable for all investors as it has not been prepared with regard to the specific investment objectives or financial situationof any particular person. Any investments discussed may not be suitable for all investors. Users of this document should seek professional advice regarding theappropriateness of investing in any securities, financial instruments or investment strategies referred to in this document and should understand that statementsregarding future prospects may not be realised. Opinions, forecasts, assumptions, estimates, derived valuations, projections, and price target(s), if any, contained inthis document are as of the date indicated and are subject to change at any time without prior notice. Our recommendations are under constant review. The valueand income of any of the securities or financial instruments mentioned in this document can fall as well as rise and an investor may get back less than invested.Future returns are not guaranteed, and a loss of original capital may be incurred. Foreign-currency denominated securities and financial instruments are subject tofluctuation in exchange rates that could have a positive or adverse effect on the value, price or income of such securities and financial instruments. Pastperformance is not indicative of comparable future results and no representation or warranty is made regarding future performance. While we endeavour to updateon a reasonable basis the information and opinions contained herein, there may be regulatory, compliance or other reasons that prevent us from doing so.

    Accordingly, information may be available to us which is not reflected in this material, and we may have acted upon or used the information prior to or immediatelyfollowing its publication. SCB is not a legal or tax adviser, and is not purporting to provide legal or tax advice. Independent legal and/or tax advice should be sought

    for any queries relating to the legal or tax implications of any investment. SCB, and/or a connected company, may have a position in any of the securities,instruments or currencies mentioned in this document. SCB and/or any member of the SCB group of companies or its respective officers, directors, employee benefitprogrammes or employees, including persons involved in the preparation or issuance of this document may at any time, to the extent permitted by applicable lawand/or regulation, be long or short any securities or financial instruments referred to in this document and on the website or have a material interest in any suchsecurities or related investment, or may be the only market maker in relation to such investments, or provide, or have provided advice, investment banking or otherservices, to issuers of such investments. SCB has in place policies and procedures and physical information walls between its Research Department and differingpublic and private business functions to help ensure confidential information, including inside information is not disclosed unless in line with its policies and

  • 8/12/2019 kaveri seeds

    5/5

    Equity Research lKaveri Seed

    26 March 2014 5

    procedures and the rules of its regulators. Data, opinions and other information appearing herein may have been obtained from public sources. SCB makes norepresentation or warranty as to the accuracy or completeness of such information obtained from public sources. You are advised to make your own independent

    judgment (with the advice of your professional advisers as necessary) with respect to any matter contained herein and not rely on this document as the basis formaking any trading, hedging or investment decision. SCB accepts no liability and will not be liable for any loss or damage arising directly or indirectly (includingspecial, incidental, consequential, punitive or exemplary damages) from use of this document, howsoever arising, and including any loss, damage or expense arisingfrom, but not limited to, any defect, error, imperfection, fault, mistake or inaccuracy with this document, its contents or associated services, or due to anyunavailability of the document or any part thereof or any contents or associated services. This material is for the use of intended recipients only and in any

    jurisdiction in which distribution to private/retail customers would require registration or licensing of the distributor which the distributor does not currently have, thisdocument is intended solely for distribution to professional and institutional investors.

    Country-Specific Disclosures - If you are receiving this document in any of the countries listed below, please note the following:United Kingdom and European Economic Area:SCB is authorised in the United Kingdom by the Prudential Regulation Authority and regulated by the FinancialConduct Authority and the Prudential Regulation Authority. This communication is not directed at Retail Clients in the European Economic Area as defined byDirective 2004/39/EC. Nothing in this document constitutes a personal recommendation or investment advice as defined by Directive 2004/39/EC.Australia:The Australian Financial Services Licence for Standard Chartered Bank is Licence No: 246833 with the following Australian Registered Business Number(ARBN: 097571778). Australian investors should note that this document was prepared for wholesale clients only within the meaning of section 761G of the

    Australian Corporations Act 2001 (Act) and the Corporations Regulations. This document is not directed at persons who are retail clients as defined in theAustralian Corporations Act 2001. Brazil:SCB disclosures pursuant to the Securities and Exchange Commission of Brazil (CVM) Instruction 483/10: This researchhas not been produced in Brazil. The report has been prepared by the research analyst(s) in an autonomous and independent way, including in relation to SCB. THESECURITIES MENTIONED IN THIS DOCUMENT HAVE NOT BEEN AND WILL NOT BE REGISTERED PURSUANT TO THE REQUIREMENTS OF THESECURITIES AND EXCHANGE COMMISSION OF BRAZIL AND MAY NOT BE OFFERED OR SOLD IN BRAZIL EXCEPT PURSUANT TO AN APPLICABLEEXEMPTION FROM THE REGISTRATION REQUIREMENTS AND IN COMPLIANCE WITH THE SECURITIES LAWS OF BRAZIL.Germany:In Germany, thisdocument is being distributed by Standard Chartered Bank Germany Branch which is also regulated by the Bundesanstalt fr Finanzdienstleistungsaufsicht (BaFin).Hong Kong: This document, except for any portion advising on or facilitating any decision on futures contracts trading, is being distributed in Hong Kong by, and is

    attributable to, Standard Chartered Bank (Hong Kong) Limited which is regulated by the Hong Kong Monetary Authority. India:This document is being distributed inIndia by Standard Chartered Securities (India) Limited which is a SEBI registered broker and a member of the Bombay Stock Exchange Limited and The NationalStock Exchange of India Limited. Korea:This document is being distributed in Korea by, and is attributable to, Standard Chartered Securities Korea Limited which isregulated by the Financial Supervisory Service. Malaysia: This document is being distributed in Malaysia by Standard Chartered Bank Malaysia Berhad only toinstitutional investors or corporate customers. Recipients in Malaysia should contact Standard Chartered Bank Malaysia Berhad in relation to any matters arisingfrom, or in connection with, this document. Singapore:This document is being distributed in Singapore by Standard Chartered Bank Singapore Branch only toaccredited investors, expert investors or institutional investors, as defined in the Securities and Futures Act, Chapter 289 of Singapore. Recipients in Singaporeshould contact Standard Chartered Bank Singapore Branch in relation to any matters arising from, or in connection with, this document. South Africa: SCB is

    licensed as a Financial Services Provider in terms of Section 8 of the Financial Advisory and Intermediary Services Act 37 of 2002. SCB is a Registered CreditProvider in terms of the National Credit Act 34 of 2005 under registration number NCRCP4. United States:Except for any documents relating to foreign exchange,FX or global FX, Rates or Commodities, distribution of this document in the United States or to US persons is intended to be solely to major institutional investors asdefined in Rule 15a-6(a)(2) under the US Securities Act of 1934. All US persons that receive this document by their acceptance thereof represent and agree thatthey are a major institutional investor and understand the risks involved in executing transactions in securities. Any US recipient of this document wanting additionalinformation or to effect any transaction in any security or financial instrument mentioned herein, must do so by contacting a registered representative of StandardChartered Securities (North America) Inc., 1095 Avenue of the Americas, New York, N.Y. 10036, US, tel + 1 212 667 0700. WE DO NOT OFFER OR SELLSECURITIES TO U.S. PERSONS UNLESS EITHER (A) THOSE SECURITIES ARE REGISTERED FOR SALE WITH THE U.S. SECURITIES AND EXCHANGECOMMISSION AND WITH ALL APPROPRIATE U.S. STATE AUTHORITIES; OR (B) THE SECURITIES OR THE SPECIFIC TRANSACTION QUALIFY FOR ANEXEMPTION UNDER THE U.S. FEDERAL AND STATE SECURITIES LAWS NOR DO WE OFFER OR SELL SECURITIES TO U.S. PERSONS UNLESS (i) WE,OUR AFFILIATED COMPANY AND THE APPROPRIATE PERSONNEL ARE PROPERLY REGISTERED OR LICENSED TO CONDUCT BUSINESS; OR (ii) WE,OUR AFFILIATED COMPANY AND THE APPROPRIATE PERSONNEL QUALIFY FOR EXEMPTIONS UNDER APPLICABLE U.S. FEDERAL AND STATE LAWS.

    Copyright 2014 Standard Chartered Bank and its affiliates. All rights reserved. All copyrights subsisting and arising out of all materials, text, articles andinformation contained herein is the property of Standard Chartered Bank and/or its affiliates, and may not be reproduced, redistributed, amended, modified, adapted,transmitted in any form, or translated in any way without the prior written permission of Standard Chartered Bank.

    Click hereto download the Standard Chartered Research app for iPad

    http://itunes.apple.com/us/app/global-research-for-ipad/id536066200?ls=1&mt=8http://itunes.apple.com/us/app/global-research-for-ipad/id536066200?ls=1&mt=8http://itunes.apple.com/us/app/global-research-for-ipad/id536066200?ls=1&mt=8http://itunes.apple.com/us/app/global-research-for-ipad/id536066200?ls=1&mt=8